Chongqing Taiji Industry(Group) Co.,Ltd

600129

CNE000000TQ2

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 03:30:00 08/05/2024 am IST			5-day change	1st Jan Change
37.61 ^CNY	-0.45%		+3.61%	-19.05%

25/04	Chongqing Taiji Industry(Group) Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
28/03	Chongqing Taiji Industry(Group) Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Chongqing Taiji Industry(Group) Co.,Ltd agreed to acquire Chongqing Taiji Chinese Medicinal Materials Planting Development Co., Ltd. from Chongqing Taiji Group Co., Ltd. and Chongqing Taiji Medicinal Animal and Plant Resources Development Co., Ltd. for CNY 8.81 million.

January 17, 2023

Chongqing Taiji Industry(Group) Co.,Ltd (SHSE:600129) agreed to acquire Chongqing Taiji Chinese Medicinal Materials Planting Development Co., Ltd. from Chongqing Taiji Group Co., Ltd. and Chongqing Taiji Medicinal Animal and Plant Resources Development Co., Ltd. for CNY 8.81 million on January 16, 2023. Chongqing Taiji Industry(Group) Co.,Ltd plans to use its own funds to solve the funds required for this equity transfer. Chongqing Taiji Industry(Group) Co.,Ltd board approved the transaction.

Latest news about Chongqing Taiji Industry(Group) Co.,Ltd

Chongqing Taiji Industry(Group) Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04	CI
Chongqing Taiji Industry(Group) Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	28/03	CI
Chongqing Chinese Medicinal Materials Co., Ltd. announced that it expects to receive CNY 48 million in funding from Chongqing Taiji Industry(Group) Co.,Ltd	28/12	CI
Chongqing Taiji Industry Unit's Fluoxetine Hydrochloride Capsules Passes Regulatory Evaluation	08/12	MT
Chongqing Taiji Industry(Group) Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	26/23/26	CI
Chongqing Taiji Industry(Group) Co.,Ltd(XSSC:600129) added to S&P Global BMI Index	18/23/18	CI
Chongqing Taiji Industry(Group) Co.,Ltd(XSSC:600129) added to FTSE All-World Index	18/23/18	CI
Chongqing Taiji Industry(Group) Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	24/23/24	CI
Chongqing Taiji Industry(Group) Co.,Ltd(SHSE:600129) added to Shanghai Stock Exchange Health Care Sector Index	12/23/12	CI
Chongqing Taiji Industry Unit's Antibiotic Passes Regulatory Evaluation in China	07/23/07	MT
Chongqing Taiji Industry(Group) Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	27/23/27	CI
Chongqing Taiji Forms Pharma Logistics JV With Affiliate	31/23/31	MT
Chongqing Taiji Industry(Group) Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	30/23/30	CI
Chongqing Taiji Industry Unit's Anti-inflammatory Medication Passes Evaluation; Shares Jump 6%	28/23/28	MT
Chongqing Taiji to Buy TCM Maker from Controlling Shareholder for 24 Million Yuan	17/23/17	MT
Chongqing Taiji Allots 198 Million Yuan to Build Pharmaceutical Logistics Center	17/23/17	MT
Chongqing Taiji Industry(Group) Co.,Ltd agreed to acquire Chongqing Taiji Chinese Medicinal Materials Planting Development Co., Ltd. from Chongqing Taiji Group Co., Ltd. and Chongqing Taiji Medicinal Animal and Plant Resources Development Co., Ltd. for CNY 8.81 million.	17/23/17	CI
Chongqing Taiji Industry(Group) Co.,Ltd agreed to acquire Chongqing Chinese Medicinal Materials Co., Ltd. from Chongqing Taiji Group Co., Ltd. for CNY 24.386 million.	17/23/17	CI
Chongqing Taiji Gets Regulatory Nod For Levofloxacin Tablets	12/22/12	MT
Chongqing Taiji Industry(Group) Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	27/22/27	CI
Chongqing Taiji Industry(Group) Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	25/22/25	CI
Chongqing Taiji Industry(Group) Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022	28/22/28	CI
Chongqing Taiji Industry(Group) Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2021	30/22/30	CI
Chongqing Taiji Industry(Group) Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021	22/21/22	CI
Chongqing Taiji Industrygroup Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2021	19/21/19	CI

Chart Chongqing Taiji Industry(Group) Co.,Ltd

Duration

Period

Chart Chongqing Taiji Industry(Group) Co.,Ltd

More charts

Company Profile

CHONGQING TAIJI INDUSTRY (GROUP) CO., LTD. is a China-based company principally engaged in the production and sales of Chinese and Western medicines. The Company is also engaged in the cultivation of medicinal herbs. The Company's products mainly include capsules, syrup, oral liquid, lyophilized series, tablets, infusion series and injections. The Company mainly conducts its business in domestic and overseas markets.

Sector

Pharmaceuticals

Calendar

16/05/2024 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Ratings for Chongqing Taiji Industry(Group) Co.,Ltd

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

37.61 CNY

Average target price

52.83 CNY

Spread / Average Target

+40.47%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
CHONGQING TAIJI INDUSTRY(GROUP) CO.,LTD	-19.05%	2.9B
ELI LILLY AND COMPANY	+32.95%	698B
NOVO NORDISK A/S	+26.51%	568B
JOHNSON & JOHNSON	-4.97%	358B
MERCK & CO., INC.	+18.83%	328B
ABBVIE INC.	+3.54%	283B
ASTRAZENECA PLC	+15.70%	238B
NOVARTIS AG	+6.68%	203B
ROCHE HOLDING AG	-9.08%	198B
AMGEN INC.	+6.70%	165B

Other Pharmaceuticals